Evidence map›Paper›PMID 33628066›Full record

ReviewMedical devices (Auckland, N.Z.)2021

Compatibility and Safety Implications Associated with Interfacing Medical Devices in Neonatal Respiratory Care: A Case Example Using the Inhaled Nitric Oxide Delivery System.

Anthony L DeWitt, Jaron Acker, Thomas A Larkin, Jim L Potenziano, Jeffrey M Schmidt

Open access · goldAbstract readReview
In one paragraph

Review in Medical devices (Auckland, N.Z.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Anthony L DeWittPenumbra Seminars, LLC, Auburn, AL, USA.
Jaron AckerMedical Device Marketing, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Thomas A LarkinDevice Engineering R&D, Mallinckrodt Pharmaceuticals Ireland Ltd., Dublin, Ireland.
Jim L PotenzianoScientific Affairs, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Jeffrey M SchmidtDevice Development, Mallinckrodt Pharmaceuticals, Madison, WI, USA.ORCID 0000-0002-3715-5896
Mallinckrodt (United States) · USMallinckrodt (Ireland) · IEPenumbra (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decade, international organizations have instituted strict regulations for the safe use of connected medical devices. The International Organization for Standardization and the Medical Device Single Audit Program instituted certifications to ensure that connected devices are compatible and operate within their proper clinical parameters. These efforts came about, in part, as a consequence of clinicians' decisions to use nonstandard, modified, or improvised devices for purposes outside the original manufacturers' approved parameters. Unapproved device modifications can be associated with increased risk of dosing errors, monitoring errors, tubing misconnections and serious or potentially fatal adverse events; furthermore, health care providers who implement unapproved device modifications may assume legal and financial liability should harm come to patients as a consequence of the modification. Using the inhaled nitric oxide delivery system as an example, the objective of this paper is to raise awareness of the potential dangers associated with unapproved modification and interfacing of therapeutic gas delivery systems and ventilators in the neonatal intensive care unit setting. The paper also highlights the rationale and necessity for rigorous validation processes that ensure that interfaced medical devices perform as intended in the clinical setting.

Indexed as

equipment failuremedical device legislationpatient safety

Identifiers

PMID33628066
PMCPMC7899041
OpenAlexW3130314215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.